Literature DB >> 14614857

GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells.

Sandrine I Samson1, Odile Richard, Manuela Tavian, Thomas Ranson, Christian A J Vosshenrich, Francesco Colucci, Jan Buer, Frank Grosveld, Isabelle Godin, James P Di Santo.   

Abstract

The GATA-3 transcription factor has a determinant role in T cell specification and is an essential mediator of T helper 2-type polarized immune responses. While both committed NK precursors and mature NK cells express GATA-3, a role of this transcription factor in murine NK cell differentiation is not known. We found that NK cells, in contrast to T cells, can be generated in the absence of GATA-3. However, while GATA-3 antagonizes IFN-gamma production in differentiating T cells, GATA-3-deficient NK cells paradoxically produced less IFN-gamma compared to control NK cells and failed to provide early protection in vivo against infection with Listeria monocytogenes. Surprisingly, GATA-3 was essential for NK cell homing to the liver. Our results suggest that GATA-3 promotes NK cell maturation and acts in this lineage to specify distinct effector phenotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614857     DOI: 10.1016/s1074-7613(03)00294-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  94 in total

1.  Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.

Authors:  Brian Becknell; Tiffany L Hughes; Aharon G Freud; Bradley W Blaser; Jianhua Yu; Rossana Trotta; Hsiaoyin C Mao; Marie L Caligiuri de Jesús; Mohamad Alghothani; Don M Benson; Amy Lehman; David Jarjoura; Danilo Perrotti; Michael D Bates; Michael A Caligiuri
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

Review 2.  NKR-P1 biology: from prototype to missing self.

Authors:  Aruz Mesci; Belma Ljutic; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3.

Authors:  Tom Taghon; Mary A Yui; Ellen V Rothenberg
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

Review 4.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 5.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 6.  Transcriptional control of natural killer cell differentiation and function.

Authors:  Alfonso Martín-Fontecha; Graham M Lord; Hugh J M Brady
Journal:  Cell Mol Life Sci       Date:  2011-08-24       Impact factor: 9.261

7.  Distal-less homeobox transcription factors regulate development and maturation of natural killer cells.

Authors:  John B Sunwoo; Sungjin Kim; Liping Yang; Tina Naik; Darryl A Higuchi; John L Rubenstein; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-29       Impact factor: 11.205

8.  NK cell maturation and function in C57BL/6 mice are altered by caloric restriction.

Authors:  Jonathan F Clinthorne; Eleni Beli; David M Duriancik; Elizabeth M Gardner
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

9.  Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.

Authors:  Shintaro Kamizono; Gordon S Duncan; Markus G Seidel; Akira Morimoto; Koichi Hamada; Gerard Grosveld; Koichi Akashi; Evan F Lind; Jillian P Haight; Pamela S Ohashi; A Thomas Look; Tak W Mak
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

10.  GATA-3 is required for early T lineage progenitor development.

Authors:  Tomonori Hosoya; Takashi Kuroha; Takashi Moriguchi; Dustin Cummings; Ivan Maillard; Kim-Chew Lim; James Douglas Engel
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.